相关实验视频

Updated: Jun 5, 2026

Clinical Application of Sleeping Beauty and Artificial Antigen Presenting Cells to Genetically Modify T Cells from Peripheral and Umbilical Cord Blood

Clinical Application of Sleeping Beauty and Artificial Antigen Presenting Cells to Genetically Modify T Cells from Peripheral and Umbilical Cord Blood

Published on: February 1, 2013

儿科形大细胞淋巴瘤的进展和更新

Lianna J Marks¹, Eric J Lowe², Kala Y Kamdar³

¹Stanford University School of Medicine, Stanford, California, United States.

|July 21, 2025

概括

儿童的无细胞大细胞淋巴瘤 (ALCL) 治疗失败率很高. 新的向疗法和分子检测方法为复发或耐药ALCL患者提供了更好的结果.

科学领域:

血液学血液学血液学
儿科瘤学儿科瘤学
免疫治疗是一种免疫疗法.

背景情况:

无塑性大细胞淋巴瘤 (ALCL) 是一种罕见的T细胞非霍奇金淋巴瘤,在儿科病例中主要是ALK阳性.
目前的化疗方案导致儿童ALCL治疗失败率为25-30%.
再发性或耐火性ALCL会带来重大的治疗挑战.

研究的目的:

审查针对性疗法和儿科ALCL分子检测的最新进展.
讨论新型治疗方法在复发和耐药环境中的作用.
突出将新策略整合到临床试验中的潜力.

主要方法:

关于ALK抑制剂,布伦图西马布维多丁和免疫疗法的最新文献的综述.
对最小传播疾病 (MDD) 和最小残留疾病 (MRD) 的分子检测技术的分析.
讨论当前的治疗模式和儿科ALCL的未来方向.

主要成果:

针对性疗法,如ALK抑制剂和布伦图西马布维多丁,在复发性/耐药性ALCL中表现出显著的活性.
检测MDD和MRD可以改善预后分层.
免疫疗法 (检查点抑制剂,CAR T细胞) 提供了额外的治疗途径.

结论:

针对性治疗和MDD/MRD评估对于改善儿科ALCL结果至关重要.
需要进一步的研究来优化治疗方案,持续时间和干细胞移植的作用.
将新型疗法和分子监测整合到临床试验中,对于推进医疗保健至关重要.

更多相关视频

Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model

Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model

Published on: February 10, 2023

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

相关概念视频

Tumor Progression

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...